Status:
COMPLETED
Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan
Lead Sponsor:
Aga Khan University
Collaborating Sponsors:
World Health Organization
Conditions:
Poliomyelitis
Eligibility:
All Genders
1-14 years
Phase:
NA
Brief Summary
Pakistan is one of the 4 developing countries where cases of poliomyelitis are still being identified. Despite the incessant efforts by WHO and UNICEF, this disease is far from control. There is a nee...
Detailed Description
The investigators propose to carry out a randomized controlled clinical trial in Pakistan to assess the efficacy of zinc supplementation in the first 18 weeks of life on seroconversion due to OPV. In...
Eligibility Criteria
Inclusion
- 0 to 14 days of healthy newborns
Exclusion
- Infants beyond 14 days of age
- Preterm infants (\< 37 weeks gestation or \< 2 kg birth weight).
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT01229579
Start Date
May 1 2010
End Date
January 1 2011
Last Update
February 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Project Office, Aga Khan University, Matiari
Matiari, Sindh, Pakistan, 71000